479
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluations

Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma

, MD (Professor of Medicine)
Pages 1141-1152 | Published online: 05 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhao Jennifer C, Jaszczur Sara Mohamed, Afifi Salma & Foss Francine. (2020) Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. Expert Review of Hematology 13:6, pages 577-583.
Read now
Thevaki Wain, Alexandra Pavli, Jillian Wells & Pablo Fernandez-Peñas. (2018) The efficacy and safety of methotrexate versus interferon in cutaneous T-cell lymphomas. Journal of Dermatological Treatment 29:7, pages 715-719.
Read now

Articles from other publishers (8)

Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism 35 67 .
Rachael A. Clark, Sora Lee, Jingbo Qiao & Dai H. Chung. (2020) Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells. Oncotarget 11:32, pages 3069-3077.
Crossref
Filiz Esra Önen Bayram, Hande Sipahi & Hülya Akgün. (2015) Acetylenic antifolates as anticancer agents. Pteridines 26:3, pages 85-92.
Crossref
M. Gooptu, R. Rhoades & B. Pro. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 289 303 .
Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, Alison Moskowitz & Christiane Querfeld. (2014) Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Journal of the American Academy of Dermatology 70:2, pages 223.e1-223.e17.
Crossref
Gandhi DamajRémy GressinKrimo BouabdallahGuillaume CartronBachra ChoufiEmmanuel GyanAnne BanosArnaud JaccardSophie ParkOlivier TournilhacJean-Marc Schiano-de CollelaLaurent VoillatBertrand JolySteven Le GouillAlain SaadPascale Cony-MakhoulJean-Pierre VilqueLaurence SanhesAline Schmidt-TanguyMichael BubenheimRoch HouotMomar DioufJean-Pierre MarolleauMarie-Christine BénéAntoine MartinThierry Lamy. (2013) Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial. Journal of Clinical Oncology 31:1, pages 104-110.
Crossref
Nitzan Gonen & Yehuda G. Assaraf. (2012) Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance. Drug Resistance Updates 15:4, pages 183-210.
Crossref
Steven M. HorwitzYoun H. KimFrancine FossJasmine M. ZainPatricia L. MyskowskiMary Jo LechowiczDavid C. FisherAndrei R. ShustovNancy L. BartlettMaria L. DelioukinaTony KoutsoukosMichael E. SaundersOwen A. O'Connor & Madeleine Duvic. (2012) Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood 119:18, pages 4115-4122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.